USP10 and Its Role in Colorectal Cancer
Author Information
Author(s): Reissland Michaela, Hartmann Oliver, Tauch Saskia, Bugter Jeroen M., Prieto-Garcia Cristian, Schulte Clemens, Loebbert Sinah, Solvie Daniel, Bitman-Lotan Eliya, Narain Ashwin, Jacomin Anne-Claire, Schuelein-Voelk Christina, Fuss Carmina T., Pahor Nikolett, Ade Carsten, Buck Viktoria, Potente Michael, Li Vivian, Beliu Gerti, Wiegering Armin, Grossmann Tom, Eilers Martin, Wolf Elmar, Maric Hans, Rosenfeldt Mathias, Maurice Madelon M., Dikic Ivan, Gallant Peter, Orian Amir, Diefenbacher Markus E.
Primary Institution: University of Wuerzburg, Germany
Hypothesis
The study investigates the role of USP10 in stabilizing β-Catenin and its implications for colorectal cancer.
Conclusion
USP10 is essential for maintaining cancer stemness and tumor growth in colorectal cancer by stabilizing β-Catenin.
Supporting Evidence
- USP10 stabilizes β-Catenin, which is critical for maintaining an undifferentiated tumor identity.
- Silencing USP10 reduces tumorigenic properties in APC-truncated colorectal cancer.
- Patient-derived organoids show dependence on USP10 for growth and survival.
- USP10 abundance correlates with poorer prognosis in colorectal cancer patients.
Takeaway
USP10 helps keep a protein called β-Catenin stable, which is important for cancer cells to grow and stay undifferentiated.
Methodology
The study used in vitro and in vivo models, including human colorectal cancer cell lines and patient-derived organoids, to investigate the role of USP10.
Limitations
The study primarily focuses on APC-truncated colorectal cancer and may not generalize to other cancer types.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website